KLK3 and pure red-cell aplasia: With the advent of improved imaging with multi-parametric magnetic resonance imaging (mpMRI) [25, 26] adding imaging to PSA and other biomarkers may be the best approach for PrCa screening, helping to reduce the number of unnecessary biopsies.